Taste Assessment of Ozanimod
- Registration Number
- NCT05001152
- Lead Sponsor
- Bristol-Myers Squibb
- Brief Summary
The purpose of this study is to assess the taste characteristics of ozanimod formulations, alone and mixed, in order to develop a pediatric oral form of ozanimod.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 7
- Men and women, between 25 and 80 years of age.
- Participant is a qualified sensory panelist selected by Senopsys based on training and experience
- Participant has any history of any illness, medical condition, laboratory abnormality, or psychiatric illness that might confound the results of the study or places the panelist at unacceptable risk if he or she were to participate in the study.
- Participant is a female that is pregnant, nursing, or planning to become pregnant during the study.
Other protocol-defined inclusion/exclusion criteria apply
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Ozanimod Ozanimod A maximum of 10 healthy adult participants (i.e., sensory panelists) will complete a maximum of 20 taste assessment days, with at least 4 panelists required to evaluate the taste characteristics of ozanimod on each taste assessment day.
- Primary Outcome Measures
Name Time Method Taste evaluation - Aromatic identity Up to 6 months Measured using the Flavor Profile method of descriptive sensory analysis
Taste evaluation - Amplitude Up to 6 months Measured using the Flavor Profile method of descriptive sensory analysis
Taste evaluation - Off-notes Up to 6 months Measured using the Flavor Profile method of descriptive sensory analysis
Taste evaluation - Aftertaste Up to 6 months Measured using the Flavor Profile method of descriptive sensory analysis
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
Senopsys LLC
🇺🇸Woburn, Massachusetts, United States
Local Institution - 0001
🇺🇸Woburn, Massachusetts, United States